Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies European Journal of Internal Medicine

Background: The characteristics and outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- positive patients with ST-Elevation Myocardial Infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) are still poorly known. Methods: The PANDEMIC study was an investigator-initiated, collaborative, individual patient data (IPD) meta-analysis of registry-based studies. MEDLINE, ScienceDirect, Web of Sciences, and SCOPUS were searched to identify all registry-based studies describing the characteristics and outcome of SARS-CoV-2-positive STEMI patients undergoing PPCI. The control group consisted of SARS-CoV-2-negative STEMI patients undergoing PPCI in the same time period from the ISACS-STEMI COVID 19 registry. The primary outcome was in-hospital mortality; the secondary outcome was postprocedural reperfusion assessed by TIMI flow. Results: Of 8 registry-based studies identified, IPD were obtained from 6 studies including 941 SARS-CoV-2-positive patients; the control group included 2005 SARS-CoV-2-negative patients. SARS-CoV-2-positive pa- tients showed a significantly higher in-hospital mortality ( p < 0.001) and worse postprocedural TIMI flow ( < 3, p < 0.001) compared with SARS-CoV-2-negative subjects. The increased risk for SARS-CoV-2-positive patients was significantly higher in males compared to females for both the primary (p interaction = 0.001) and secondary outcome (p interaction = 0.023). In SARS-CoV-2-positive patients, age ≥ 75 years (OR = 5.72; 95%CI: 1.77 – 18.5), impaired postprocedural TIMI flow (OR = 11.72; 95%CI: 2.64 – 52.10), and cardiogenic shock at presentation (OR = 11.02; 95%CI: 2.84 – 42.80) were independent predictors of mortality. Conclusions: In STEMI patients undergoing PPCI, SARS-CoV-2 positivity is independently associated with impaired reperfusion and with a higher risk of in-hospital mortality, especially among male patients. Age ≥ 75 years, cardiogenic shock, and impaired postprocedural TIMI flow independently predict mortality in this high- risk population.

[1]  M. Brandi Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic? , 2021, Reviews in Endocrine and Metabolic Disorders.

[2]  A. Bollmann,et al.  Sex Differences in Clinical Course and Intensive Care Unit Admission in a National Cohort of Hospitalized Patients with COVID-19 , 2021, Journal of clinical medicine.

[3]  H. Suryapranata,et al.  COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction , 2021, Heart.

[4]  M. Morello,et al.  Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19. , 2021, European review for medical and pharmacological sciences.

[5]  D. Tousoulis,et al.  Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA) , 2021, Cardiovascular research.

[6]  G. De Luca,et al.  COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives , 2021, Oxidative medicine and cellular longevity.

[7]  Z. Siudak,et al.  Treatment Delay and Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction during the COVID-19 Pandemic , 2021, Journal of clinical medicine.

[8]  J. C. Rama-Merchán,et al.  Angiographic and Clinical Profile of Patients With COVID-19 Referred for Coronary Angiography During SARS-CoV-2 Outbreak: Results From a Collaborative, European, Multicenter Registry , 2021, Angiology.

[9]  Massimo Siviglia,et al.  Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry , 2021, Atherosclerosis.

[10]  M. Karabacak,et al.  Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry) , 2021, Journal of Thrombosis and Thrombolysis.

[11]  B. Gersh,et al.  International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19 , 2021, Journal of the American College of Cardiology.

[12]  Brian C. Case,et al.  Initial Findings From the North American COVID-19 Myocardial Infarction Registry , 2021, Journal of the American College of Cardiology.

[13]  G. De Luca,et al.  Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients , 2021, BMC Cardiovascular Disorders.

[14]  Massimo Siviglia,et al.  Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI , 2020, Journal of the American College of Cardiology.

[15]  M. Ciccarelli,et al.  Timing of national lockdown and mortality in COVID-19: The Italian experience , 2020, International Journal of Infectious Diseases.

[16]  D. Xiang,et al.  Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China , 2020, Journal of the American College of Cardiology.

[17]  A. Baumbach,et al.  High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction , 2020, Journal of the American College of Cardiology.

[18]  C. Siu,et al.  Impact of coronavirus disease 2019 (COVID‐19) outbreak on outcome of myocardial infarction in Hong Kong, China , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[19]  C. Schmidt,et al.  Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic , 2020, Journal of the American College of Cardiology.

[20]  Mohammad Madjid,et al.  Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.

[21]  H. Suryapranata,et al.  Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. , 2015, Diabetes & metabolism.

[22]  Richard D Riley,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .

[23]  H. Suryapranata,et al.  Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. , 2013, International journal of cardiology.

[24]  G. Stone,et al.  Impact of Diabetes on Long-Term Outcome After Primary Angioplasty , 2013, Diabetes Care.

[25]  D. Dudek,et al.  Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb–IIIa inhibitors: insights from the EGYPT cooperation , 2010, Journal of Thrombosis and Thrombolysis.

[26]  G. De Luca,et al.  Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials , 2009, European heart journal.

[27]  A. Kastrati,et al.  Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[28]  J. Ottervanger,et al.  Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. , 2006, Atherosclerosis.

[29]  J. Ottervanger,et al.  Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. , 2005, European heart journal.

[30]  Felix Zijlstra,et al.  Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty: Implications for Early Discharge , 2004, Circulation.

[31]  J. Ottervanger,et al.  Impaired Myocardial Perfusion Is a Major Explanation of the Poor Outcome Observed in Patients Undergoing Primary Angioplasty for ST-Segment–Elevation Myocardial Infarction and Signs of Heart Failure , 2004, Circulation.

[32]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[33]  Donald Rubin,et al.  Estimating Causal Effects from Large Data Sets Using Propensity Scores , 1997, Annals of Internal Medicine.

[34]  D B Rubin,et al.  Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.

[35]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[36]  B. Ibáñez,et al.  In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients , 2021, EuroIntervention.

[37]  J. Rumsfeld,et al.  Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention. , 2009, JACC. Cardiovascular interventions.